|Articles|December 1, 2015
- Applied Clinical Trials-12-01-2015
- Volume 24
- Issue 12
Applied Clinical Trials Digital Edition - December 2015/January 2016
Regulatory: Assessing Study Drop in CEE Swiss Syncs Up Regulations Sites: Regional Risks in Eastern Europe Also in this issue: Orphan Drug Hurdles in Europe Patient Engagement: Illness-Level Impact Clinical Trial Technology in 2025
Advertisement
Articles in this issue
over 10 years ago
Orphans of the Stormover 10 years ago
Technology-Driven R&D to be Prime Topic at DIA’s EuroMeetingover 10 years ago
How Will Technology Drive Global Clinical Trial Change by 2025?over 10 years ago
New EU Trials Law: Headway, Concernsover 10 years ago
Switzerland Guides Innovation in Clinical Trial Regulationsover 10 years ago
Decline of Trials in CEE: Fluctuation or Trend?over 10 years ago
Site Challenges in Eastern Europeover 10 years ago
Rethinking Patient Engagement: Mild vs. Severe Illnessover 10 years ago
Patients, PDUFA, Pandemics to Shape R&D in 2016over 10 years ago
Applied Clinical Trials, December 2015/January 2016 Issue (PDF)Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Applied Clinical Trials at the 2026 DIA Global Annual Meeting: Conversations on Data, Outsourcing, and the Patient Voice
2
Nature Medicine Retracts Viral Lung Cancer Timing Study After Four-Month Investigation
3
ACT Brief: Bridging Site-Sponsor Data Gaps, Major Study Retraction, and TNBC First-Line Approval
4
Real-Time Clinical Trials: What the FDA's Push Toward Continuous Oversight Means for Sponsors
5